Efficacy, Safety, and Tolerability of a Novel Cyclosporine, a Formulation for Dry Eye Disease: A Multicenter Phase II Clinical Study - Peng, Wen-yan; Chen, Rong-xin; Dai, Hong; Zhu, Lei; Li, Ying; Gao, Zi-qing; Li, Xiao-yi; Zhou, Shi-you (Clinical therapeutics, 2021)
Keywords: Adverse events; Burning; Chronic fatigue syndrome; Clinical trials; Cornea; cyclosporine; Cyclosporins; Dosage; Drug dosages; dry eye disease; efficacy; Eye diseases; Fluorescein; Immunomodulators; Internal Medicine; multicenter Phase II clinical study; Patients; Pruritus; Safety; Statistical analysis; Surgery; tolerability; United States--US; China; cyclosporine; dry eye disease; multicenter Phase II clinical study; safety; efficacy; tolerability